M. Kraus & CO Merck & Co., Inc. Transaction History

M. Kraus & CO

$309 Million
Q3 2024

A detailed history of M. Kraus & CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, M. Kraus & CO holds 11,954 shares of MRK stock, worth $1.22 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

11,954

Previous 12,204 2.05%

Holding current value

$1.22 Million

Previous $1.51 Million 10.13%

% of portfolio

0.44%

Previous 0.51%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$111.15 - $128.97 $27,787 - $32,242	-250 Reduced 2.05%	11,954 $1.36 Million
Q2 2024 Jul 10, 2024	SELL	$123.8 - $132.96 $23,274 - $24,996	-188 Reduced 1.52%	12,204 $1.51 Million
Q1 2024 Apr 10, 2024	SELL	$113.24 - $131.95 $36,803 - $42,883	-325 Reduced 2.56%	12,392 $1.64 Million
Q4 2023 Jan 10, 2024	SELL	$100.18 - $109.02 $71,127 - $77,404	-710 Reduced 5.29%	12,717 $1.39 Million
Q3 2023 Oct 16, 2023	SELL	$102.95 - $114.33 $57,343 - $63,681	-557 Reduced 3.98%	13,427 $1.38 Million
Q2 2023 Jul 14, 2023	SELL	$108.61 - $118.38 $33,669 - $36,697	-310 Reduced 2.17%	13,984 $1.61 Million
Q1 2023 Apr 18, 2023	BUY	$102.94 - $114.86 $22,646 - $25,269	220 Added 1.56%	14,294 $1.52 Million
Q4 2022 Jan 25, 2023	BUY	$87.44 - $112.11 $334,195 - $428,484	3,822 Added 37.28%	14,074 $0
Q3 2022 Oct 27, 2022	BUY	$84.53 - $94.96 $1,690 - $1,899	20 Added 0.2%	10,252 $883,000
Q1 2022 Apr 18, 2022	BUY	$73.51 - $82.4 $55,867 - $62,624	760 Added 8.02%	10,232 $840,000
Q4 2021 Jan 19, 2022	SELL	$72.28 - $90.54 $7,228 - $9,054	-100 Reduced 1.04%	9,472 $726,000
Q3 2021 Oct 18, 2021	BUY	$71.68 - $78.83 $2,078 - $2,286	29 Added 0.3%	9,572 $719,000
Q2 2021 Jul 21, 2021	SELL	$70.31 - $77.77 $1,757 - $1,944	-25 Reduced 0.26%	9,543 $742,000
Q1 2021 Apr 19, 2021	BUY	$68.86 - $81.11 $3,167 - $3,731	46 Added 0.48%	9,568 $738,000
Q4 2020 Jan 13, 2021	BUY	$71.77 - $79.65 $15,861 - $17,602	221 Added 2.38%	9,522 $779,000
Q1 2020 Apr 14, 2020	SELL	$63.36 - $87.82 $1,013 - $1,405	-16 Reduced 0.17%	9,301 $716,000
Q2 2019 Jul 17, 2019	BUY	$69.84 - $81.59 $40,856 - $47,730	585 Added 6.7%	9,317 $781,000
Q1 2019 Apr 15, 2019	SELL	$69.58 - $79.36 $4,731 - $5,396	-68 Reduced 0.77%	8,732 $726,000
Q4 2018 Jan 15, 2019	SELL	$65.24 - $75.71 $3,588 - $4,164	-55 Reduced 0.62%	8,800 $672,000
Q3 2018 Oct 23, 2018	BUY	$57.69 - $67.84 $57,690 - $67,840	1,000 Added 12.73%	8,855 $628,000
Q1 2018 Apr 19, 2018	SELL	$50.96 - $59.23 $10,192 - $11,846	-200 Reduced 2.48%	7,855 $428,000
Q4 2017 Jan 18, 2018	BUY	$51.62 - $61.64 $19,512 - $23,299	378 Added 4.92%	8,055 $453,000
Q3 2017 Oct 17, 2017	BUY	$58.67 - $63.13 $450,409 - $484,649	7,677	7,677 $492,000

Others Institutions Holding MRK

# of Institutions

3,807

Shares Held

1.92B

Call Options Held

13.4M

Put Options Held

10.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $258B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M. Kraus & CO, based on Form 13F filings with the SEC.

News

Stay updated on M. Kraus & CO with notifications on news.

Account